Randomised Controlled TrialiVNSn = 239

Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial

Ikramuddin S, Blackstone RP, Brancatisano A, Toouli J, Shah SN, Wolfe BM, Fujioka K, Maher JW, Swain J, Que FG, et al.

JAMA · 2014

Key finding

In 239 patients, vagal nerve block produced 24.4% excess weight loss versus 15.9% with sham at 12 months, meeting the trial's a-priori safety threshold but not its efficacy margin over sham.

Condition
Obesity
Stimulation
iVNS
Evidence tier
Randomised Controlled Trial
Participants
239
View on DOI

Cite this study

Ikramuddin, S., Blackstone, R. P., Brancatisano, A., Toouli, J., Shah, S. N., Wolfe, B. M., Fujioka, K., Maher, J. W., Swain, J., Que, F. G., Morton, J. M., Leslie, D. B., Brancatisano, R., Kow, L., O’Rourke, R. W., Deveney, C., Takata, M., Miller, C. J., Knudson, M. B., … Billington, C. J. (2014). Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial. JAMA, 312(9), 915. https://doi.org/10.1001/jama.2014.10540

Related studies in Obesity

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.